Metraipolis › archive › dc_6ed320104083

Electrocardiographic effects of HBI-3000 (sulcardine sulfate), a new drug for termination of atrial fibrillation — Europe PMC PMID:41737939

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41737939
DOI
10.1016/j.hroo.2025.11.019
License (as archived)
solo-consultazione
Archived
2026-11-07T02:35:08.617Z
SHA-256 of the archived text
11df24da123ac6905ad01ac883d3048664b33a11ae5383e86126244f7f2652db
Stable URL of this page
https://metraipolis.com/documento/dc_6ed320104083

How to cite

Electrocardiographic effects of HBI-3000 (sulcardine sulfate), a new drug for termination of atrial fibrillation — Europe PMC PMID:41737939 — Europe PMC (en), https://europepmc.org/article/MED/41737939 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ed320104083 (Metraipolis archive dc_6ed320104083, sha256 11df24da123ac6905ad01ac883d3048664b33a11ae5383e86126244f7f2652db)
BibTeX
@misc{dc6ed320104083,
  title = {Electrocardiographic effects of HBI-3000 (sulcardine sulfate), a new drug for termination of atrial fibrillation — Europe PMC PMID:41737939},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41737939},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ed320104083; sha256 11df24da123ac6905ad01ac883d3048664b33a11ae5383e86126244f7f2652db},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41737939. Agents can read the archived copy with the MCP tool read_document.